• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchStatera Biopharma
    Picture of Statera Biopharma logo

    STAB — Statera Biopharma News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.01m
    • Enterprise Value
      $5.97m
    • Revenue
      $1.49m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • STAB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    STAB Dividends
    All News

    NASDAQ RESUMED AT 10:04 AM

    Picture of Statera Biopharma logoStatera Biopharma
    27/02/2020 15:04
    NASDAQ RESUMED  CBLI.O  AT 10:04 AM
    

    Recent news on Statera Biopharma

    See all news
    • 20/20 Biolabs jumps on Ebola, hantavirus testing plans

      22/05/2026 14:11
    • Tivic Health Systems rises after deal for late-stage immunotherapy drug

      12/02/2025 19:22
    • Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist

      12/02/2025 13:34
    • Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20

      21/10/2022 14:14
    • Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc

      18/10/2022 11:27

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.